Company now has 44 dispensaries in Florida and 123 nationwide

January 19, 2022  — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced plans to open two new dispensaries in Florida by the end of this month. The expansion will increase the Company’s retail footprint to 44 dispensaries statewide and 123 across the country.

Curaleaf Tampa Bay Mabry, located at 13755 North Dale Mabry Highway, opened on January 15th and Curaleaf Largo, located at 10289 Ulmerton Road, is expected to open later this month, subject to final regulatory approvals. In December, Curaleaf added four additional dispensaries in StuartLady LakeWesley Chapel and Miami to continue to expand access to the company’s quality products and services.

Florida has evolved into one of the largest and fastest growing medical markets in the country. Curaleaf has quickly expanded its retail presence and cultivation footprint and introduced more innovative products, including Select Squeeze, Select Bites, Select Nano Bites, and its breakthrough vape hardware Cliq by Select, which features a proprietary gravity-fed pod and variable battery voltage settings, allowing patients to customize cannabis consumption experiences to their individual preferences. The company’s Florida growth strategy resulted in significant gains last year, with Curaleaf doubling its market share to fifteen percent in the state.

“We are excited to kick off this year continuing our momentum of expansion and growth in Florida,” said Matt Darin, President of Curaleaf. “Throughout this year our patients can expect to see Curaleaf continue to lead the Florida market with new innovative products and convenient new locations.”

For more information on Curaleaf’s latest openings in Florida, along with product offerings and hours of operation, please visit

About Curaleaf Holdings 
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 123 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit